Healthcare provider profile · identity verified

Kyle Trauth, M.D.

Family Practice · MORRILTON, AR · NPI 1922268911

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	361	109
Gabapentin	Gabapentin	228	64
Lisinopril	Lisinopril	193	50
Metformin Hcl	Metformin Hcl	172	50
Amlodipine Besylate	Amlodipine Besylate	166	45
Levothyroxine Sodium	Levothyroxine Sodium	160	41
Furosemide	Furosemide	133	37
Pantoprazole Sodium	Pantoprazole Sodium	126	40
Ozempic	Semaglutide	116	21
Metoprolol Succinate	Metoprolol Succinate	113	37
Omeprazole	Omeprazole	105	36
Potassium Chloride	Potassium Chloride	103	34
Trulicity	Dulaglutide	101	19
Losartan Potassium	Losartan Potassium	98	24
Rosuvastatin Calcium	Rosuvastatin Calcium	90	23
Sertraline Hcl	Sertraline Hcl	87	21
Xarelto	Rivaroxaban	86	suppressed
Carvedilol	Carvedilol	79	20
Escitalopram Oxalate	Escitalopram Oxalate	78	17
Montelukast Sodium	Montelukast Sodium	75	17
Metoprolol Tartrate	Metoprolol Tartrate	72	21
Albuterol Sulfate Hfa	Albuterol Sulfate	70	26
Eliquis	Apixaban	70	12
Tamsulosin Hcl	Tamsulosin Hcl	67	19
Divalproex Sodium	Divalproex Sodium	66	suppressed
Trazodone Hcl	Trazodone Hcl	65	21
Pregabalin	Pregabalin	62	13
Spironolactone	Spironolactone	59	13
Tramadol Hcl	Tramadol Hcl	57	12
Diclofenac Sodium	Diclofenac Sodium	56	14
Duloxetine Hcl	Duloxetine Hcl	56	16
Allopurinol	Allopurinol	55	19
Finasteride	Finasteride	55	15
Warfarin Sodium	Warfarin Sodium	55	suppressed
Prednisone	Prednisone	53	30
Bumetanide	Bumetanide	44	16
Fluticasone Propionate	Fluticasone Propionate	42	15
Fluoxetine Hcl	Fluoxetine Hcl	41	14
Alendronate Sodium	Alendronate Sodium	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	40	12
Farxiga	Dapagliflozin Propanediol	39	suppressed
Meloxicam	Meloxicam	38	16
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	11
Mounjaro	Tirzepatide	37	suppressed
Lorazepam	Lorazepam	36	suppressed
Naproxen	Naproxen	35	12
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	32	suppressed
Myrbetriq	Mirabegron	32	suppressed
Baclofen	Baclofen	31	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Tresiba Flextouch U-200	Insulin Degludec	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Cephalexin	Cephalexin	26	24
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Olanzapine	Olanzapine	25	suppressed
Atenolol	Atenolol	24	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Doxepin Hcl	Doxepin Hcl	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Spiriva Respimat	Tiotropium Bromide	22	suppressed
Glipizide	Glipizide	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Fluconazole	Fluconazole	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Estradiol	Estradiol	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Azithromycin	Azithromycin	18	11
Entresto	Sacubitril/Valsartan	18	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Kerendia	Finerenone	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Linzess	Linaclotide	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Primidone	Primidone	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	13	suppressed
Cosentyx Syringe	Secukinumab	12	suppressed
Dexamethasone	Dexamethasone	12	12
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Jardiance	Empagliflozin	11	suppressed
M-Natal Plus	Pnv,calcium 72/Iron/Folic Acid	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error